N@N

Market Maker Surveillance Report. BSX, C, BMO, JPM, ACTC, GRPN, Bullishly Biased Price Friction For Monday, January 7th 2013

January 7, 2013 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 3999 companies with "abnormal" market making, 2718 companies with positive Friction Factors and 2830 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bullish bias) in their stock prices. This means that there was more selling than buying in the stocks and their stock prices rose. Boston Scientific Corp (NYSE:BSX), Citigroup Inc (NYSE:C), Bank of Montreal (NYSE:BMO), JPMorgan Chase & Co (NYSE:JPM), Advanced Cell Technology Inc (OTCBB:ACTC), Groupon Inc (NASDAQ:GRPN). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  BSX     $0.060    1.02%     5,290,849    21.97%    7,510,467    31.19%    -2,219,618   Abnormal
  C       $0.040    0.09%     10,460,061   28.84%    12,502,000   34.47%    -2,041,939   Abnormal
  BMO     $0.190    0.30%     176,108      8.68%     1,689,891    83.29%    -1,513,783   Abnormal
  JPM     $0.050    0.11%     6,847,351    28.07%    8,993,720    36.86%    -2,146,369   Abnormal
  ACTC    $0.010    12.52%    35,141,535   47.92%    38,083,649   51.93%    -2,942,114   Abnormal
  GRPN    $0.020    0.35%     7,567,389    44.85%    9,104,515    53.96%    -1,537,126   Abnormal

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above had more selling than buying on Monday and their stock prices rose. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows BSX with 2,219,618 greater shares of selling than buying (NetVol) and the stock price was up $0.06000. This means the Market Makers were trading the stock in a way inconsistent with normal supply and demand (Economics 101); more selling than buying should cause prices to drop.

Boston Scientific Corp (NYSE:BSX) - Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. The company offers interventional cardiology products, including coronary stent systems used in the treatment of coronary artery disease; coronary revascularization products, such as balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices, and diagnostic catheters used in percutaneous transluminal coronary angioplasty; intraluminal ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems. It also provides cardiac rhythm management devices consisting of implantable cardioverter defibrillator, and implantable pacemaker systems that monitor the heart and deliver electricity to treat cardiac abnormalities; endoscopy products, such as devices to treat diseases of the digestive and pulmonary systems; and peripheral interventions to treat patients with peripheral diseases. In addition, the company offers devices comprising mid-urethral sling products, sling materials, graft materials, pelvic floor reconstruction kits, and suturing devices to treat urinary stone disease, stress urinary incontinence, pelvic organ prolapse, and excessive uterine bleeding. Further, it provides neuromodulation products used for the management of chronic pain; and medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart, such as frequency (RF) generators, steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. Additionally, it offers implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities; and implantable pacemaker systems used to manage slow or irregular heart rhythms. The company was founded in 1979 and is headquartered in Natick, Massachusetts..

Citigroup Inc (NYSE:C) - Citigroup, Inc., a diversified financial services holding company, provides a range of financial products and services to consumers, corporations, governments, and institutions worldwide. The company operates through two segments, Citicorp and Citi Holdings. The Citicorp segment operates as a global bank for businesses and consumers with two primary businesses, Global Consumer Banking and Institutional Clients Group. The Global Consumer Banking business provides retail banking and Citi-branded cards in North America; Asia; Latin America; and Europe, the Middle East, and Africa (EMEA). The Institutional Clients Group business provides securities and banking services comprising investment banking and advisory services, lending, debt and equity sales and trading, institutional brokerage, derivative services, and private banking; and transaction services consisting of treasury and trade solutions, and securities and fund services. The Citi Holdings segment operates Brokerage and Asset Management, Local Consumer Lending, and Special Asset Pool businesses. The Brokerage and Asset Management business, through its Morgan Stanley Smith Barney joint venture, offers retail brokerage and asset management services. The Local Consumer Lending business provides residential mortgages, retail partner card loans, student loans, personal loans, commercial real estate, and other consumer loans and assets, as well as western European cards and retail banking services. The Special Asset Pool business consists of a portfolio of securities, loans, and other assets. The company has approximately 200 million customer accounts and operates in approximately 160 countries and jurisdictions. As of December 31, 2011, it had 1,016 retail bank branches in North America; 292 retail branches in EMEA; 2,221 retail branches in Latin America; and 671 retail branches in Asia. Citigroup, Inc. was founded in 1812 and is based in New York, New York..

Bank of Montreal (NYSE:BMO) - Bank of Montreal, together with its subsidiaries, provides various retail banking, wealth management, and investment banking products and services in North America and internationally. It offers personal banking products and services, including deposit and investment services, mortgages, consumer credit, loans, credit cards, financial planning, insurance, and other banking services to individuals, and small and mid-sized businesses; and commercial banking products and services comprising specialized banking, business accounts and plans, credit cards, business loans and commercial mortgages, cash management, investing, foreign exchange, and financial advisory to small business, medium-sized enterprise, and mid-market banking clients. The company also provides capital raising, investing, advisory, treasury, and research services to corporate, institutional, and government clients; and wealth management products and solutions, including insurance products for mainstream, ultra-high net worth, and institutional client segments. As of October 31, 2012, it maintained approximately 1,570 bank branches in Canada and the United States. The company was founded in 1817 and is headquartered in Montreal, Canada..

JPMorgan Chase & Co (NYSE:JPM) - JPMorgan Chase & Co., a financial holding company, provides various financial services worldwide. Its Investment Bank segment offers various investment banking products and services, including advising on corporate strategy and structure, capital-raising in equity and debt markets, risk management, market-making in cash securities and derivative instruments, prime brokerage, and research services for corporations, financial institutions, governments, and institutional investors. The company s Commercial Banking segment provides lending, treasury, investment banking, and asset management services to corporations, municipalities, financial institutions, and not-for-profit entities. Its Treasury and Securities Services segment offers cash management, trade, wholesale card, and liquidity products and services to small and mid-sized companies, multinational corporations, financial institutions, and government entities. This segment also holds, values, clears, and services securities, cash, and alternative investments for investors and broker-dealers; and manages depositary receipt programs. The company s Asset Management segment provides investment and wealth management services to institutions, retail investors, and high-net-worth individuals. This segment offers investment management in equities, fixed income, real estate, hedge funds, private equity, and liquidity products, as well as trust and estate, banking, and brokerage services to high-net-worth clients; and retirement services for corporations and individuals. Its Retail Financial Services segment offers consumer and business, and mortgage banking products and services that include checking and savings accounts, mortgages, home equity and business loans, and investments. The company s Card Services and Auto segment provides payment processing and merchant acquiring services. JPMorgan Chase & Co. was founded in 1823 and is headquartered in New York, New York..

Advanced Cell Technology Inc (OTCBB:ACTC) - Advanced Cell Technology, Inc., a biotechnology company, engages in the development and commercialization of human embryonic, induced pluripotency, and adult stem cell technology in the field of regenerative medicine. It has developed a range of intellectual property portfolio for specific applications of stem cell technology in producing retinal pigment epithelium cells, hemangioblasts, myoblast stem cells, and various methods and compositions for the use of these technologies and derived cells in treating retinal and other eye diseases, inflammatory and autoimmune diseases, and heart diseases, as well as to provide agents for wound healing and replacement of blood components. The company s human embryonic stem cell technologies comprise cellular reprogramming and pluripotent stem cell technologies to produce cells that have the proliferative capacity of embryonic stem cells with therapeutic application and compatible with the patient. Its cell therapy research programs include retinal pigment epithelium and hemangioblast programs; and stable cell lines with particular focus on blood lineage and vascular epithelial cell lines from hemangioblast cells. The company s adult stem cell program develops an autologous myoblast transplantation therapy to restore cardiac function in patients with advanced heart diseases. Advanced Cell Technology, Inc. develops and maintains an intellectual property portfolio, with ownership or licensing of approximately 35 issued patents and approximately 170 patent applications in the field of regenerative medicine and related areas. The company is headquartered in Marlborough, Massachusetts..

Groupon Inc (NASDAQ:GRPN) - GREATER PA CORP.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net

Contributing Sources

---